Literature DB >> 29516993

Bipolar disorders.

Eduard Vieta1, Michael Berk2,3,4, Thomas G Schulze5,6,7,8,9, André F Carvalho10,11, Trisha Suppes12,13, Joseph R Calabrese14,15, Keming Gao14,15, Kamilla W Miskowiak16,17, Iria Grande1.   

Abstract

Bipolar disorders are chronic and recurrent disorders that affect >1% of the global population. Bipolar disorders are leading causes of disability in young people as they can lead to cognitive and functional impairment and increased mortality, particularly from suicide and cardiovascular disease. Psychiatric and nonpsychiatric medical comorbidities are common in patients and might also contribute to increased mortality. Bipolar disorders are some of the most heritable psychiatric disorders, although a model with gene-environment interactions is believed to best explain the aetiology. Early and accurate diagnosis is difficult in clinical practice as the onset of bipolar disorder is commonly characterized by nonspecific symptoms, mood lability or a depressive episode, which can be similar in presentation to unipolar depression. Moreover, patients and their families do not always understand the significance of their symptoms, especially with hypomanic or manic symptoms. As specific biomarkers for bipolar disorders are not yet available, careful clinical assessment remains the cornerstone of diagnosis. The detection of hypomanic symptoms and longtudinal clinical assessment are crucial to differentiate a bipolar disorder from other conditions. Optimal early treatment of patients with evidence-based medication (typically mood stabilizers and antipsychotics) and psychosocial strategies is necessary.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29516993     DOI: 10.1038/nrdp.2018.8

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   52.329


  109 in total

1.  Bipolar II Disorder: Frequent, Valid, and Reliable.

Authors:  Eduard Vieta
Journal:  Can J Psychiatry       Date:  2019-08       Impact factor: 4.356

Review 2.  Perspective on Etiology and Treatment of Bipolar Disorders in China: Clinical Implications and Future Directions.

Authors:  Zuowei Wang; Chen Jun; Keming Gao; Haichen Yang; Yiru Fang
Journal:  Neurosci Bull       Date:  2019-05-16       Impact factor: 5.203

3.  The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis.

Authors:  J A Arnaiz; C Rodrigues-Silva; G Mezquida; S Amoretti; M J Cuesta; D Fraguas; A Lobo; A González-Pinto; M C Díaz-Caneja; I Corripio; E Vieta; I Baeza; A Mané; C García-Rizo; M Bioque; J Saiz; M Bernardo; S Mas
Journal:  Psychopharmacology (Berl)       Date:  2020-11-23       Impact factor: 4.530

4.  Childhood factors associated with increased risk for mood episode recurrences in bipolar disorder-A systematic review.

Authors:  Xavier Estrada-Prat; Anna R Van Meter; Ester Camprodon-Rosanas; Santiago Batlle-Vila; Benjamin I Goldstein; Boris Birmaher
Journal:  Bipolar Disord       Date:  2019-05-15       Impact factor: 6.744

Review 5.  Translational genomics and beyond in bipolar disorder.

Authors:  Chen Zhang; Xiao Xiao; Tao Li; Ming Li
Journal:  Mol Psychiatry       Date:  2020-05-18       Impact factor: 15.992

6.  Risk of Developing Parkinson Disease in Bipolar Disorder: A Systematic Review and Meta-analysis.

Authors:  Patrícia R Faustino; Gonçalo S Duarte; Inês Chendo; Ana Castro Caldas; Sofia Reimão; Ricardo M Fernandes; José Vale; Michele Tinazzi; Kailash Bhatia; Joaquim J Ferreira
Journal:  JAMA Neurol       Date:  2020-02-01       Impact factor: 18.302

7.  Content overlap analysis of 64 (hypo)mania symptoms among seven common rating scales.

Authors:  Adrian A Chrobak; Marcin Siwek; Dominika Dudek; Janusz K Rybakowski
Journal:  Int J Methods Psychiatr Res       Date:  2018-07-30       Impact factor: 4.035

Review 8.  Cardiovascular disease in patients with severe mental illness.

Authors:  René Ernst Nielsen; Jytte Banner; Svend Eggert Jensen
Journal:  Nat Rev Cardiol       Date:  2020-10-30       Impact factor: 32.419

9.  Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications.

Authors:  Alessio Squassina; Mirko Manchia; Claudia Pisanu; Raffaella Ardau; Carlo Arzedi; Alberto Bocchetta; Paola Caria; Cristina Cocco; Donatella Congiu; Eleonora Cossu; Tinuccia Dettori; Daniela Virginia Frau; Mario Garzilli; Elias Manca; Anna Meloni; Maria Antonietta Montis; Andrea Mura; Mariella Nieddu; Barbara Noli; Pasquale Paribello; Federica Pinna; Renato Robledo; Giovanni Severino; Valeria Sogos; Maria Del Zompo; Gian Luca Ferri; Caterina Chillotti; Roberta Vanni; Bernardo Carpiniello
Journal:  Neuropsychopharmacology       Date:  2020-09-12       Impact factor: 7.853

Review 10.  Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability.

Authors:  Balázs Pál
Journal:  Cell Mol Life Sci       Date:  2018-05-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.